MCID: MYC007
MIFTS: 81

Myocardial Infarction

Categories: Genetic diseases, Cardiovascular diseases

Aliases & Classifications for Myocardial Infarction

MalaCards integrated aliases for Myocardial Infarction:

Name: Myocardial Infarction 53 37 12 36 28 51 41 14 69
Heart Attack 12 72 40 59
Myocardial Infarction 1 71 28
Myocardial Infarction, Decreased Susceptibility to 53
Myocardial Infarction, Protection Against 53
Myocardial Infarction, Susceptibility to 53
Myocardial Infarction, Decreased 53
Premature Myocardial Infarction 71
Myocardial Infarct 12
Mci1 71

Classifications:



External Ids:

OMIM 53 608446
Disease Ontology 12 DOID:5844
ICD10 32 I21 I22
MeSH 41 D009203
NCIt 46 C27996
KEGG 36 H01730
UMLS 69 C0027051

Summaries for Myocardial Infarction

MedlinePlus : 40 Each year almost 800,000 Americans have a heart attack. A heart attack happens when blood flow to the heart suddenly becomes blocked. Without the blood coming in, the heart can't get oxygen. If not treated quickly, the heart muscle begins to die. But if you do get quick treatment, you may be able prevent or limit damage to the heart muscle. That's why it's important to know the symptoms of a heart attack and call 9-1-1 if you or someone else is having them. You should call, even if you are not sure that it is a heart attack. The most common symptoms in men and women are Chest discomfort. It is often in center or left side of the chest. It usually lasts more than a few minutes. It may go away and come back. It can feel like pressure, squeezing, fullness, or pain. It also can feel like heartburn or indigestion. Shortness of breath. Sometimes this is your only symptom. You may get it before or during the chest discomfort. It can happen when you are resting or doing a little bit of physical activity. Discomfort in the upper body. You may feel pain or discomfort in one or both arms, the back, shoulders, neck, jaw, or upper part of the stomach. You may also have other symptoms, such as nausea, vomiting, dizziness, and lightheadedness. You may break out in a cold sweat. Sometimes women will have different symptoms then men. For example, they are more likely to feel tired for no reason. The most common cause of heart attacks is coronary artery disease (CAD). With CAD, there is a buildup of cholesterol and other material, called plaque, on their inner walls or the arteries. This is atherosclerosis. It can build up for years. Eventually an area of plaque can rupture (break open). A blood clot can form around the plaque and block the artery. A less common cause of heart attack is a severe spasm (tightening) of a coronary artery. The spasm cuts off blood flow through the artery. At the hospital, health care providers make a diagnosis based on your symptoms, blood tests, and different heart health tests. Treatments may include medicines and medical procedures such as coronary angioplasty. After a heart attack, cardiac rehabilitation and lifestyle changes can help you recover. NIH: National Heart, Lung, and Blood Institute

MalaCards based summary : Myocardial Infarction, also known as heart attack, is related to myocardial infarction 2 and anterolateral myocardial infarction, and has symptoms including edema, chest pain and angina pectoris. An important gene associated with Myocardial Infarction is ITGB3 (Integrin Subunit Beta 3), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and A-beta Pathways: Plaque Formation and APP Metabolism. The drugs Etanercept and Abciximab have been mentioned in the context of this disorder. Affiliated tissues include Bone and Limb, and related phenotypes are cardiovascular system and homeostasis/metabolism

Disease Ontology : 12 A coronary artery disease characterized by myocardial cell death (myocardial necrosis) due to prolonged ischaemia.

UniProtKB/Swiss-Prot : 71 Myocardial infarction 1: A condition defined by the irreversible necrosis of heart muscle secondary to prolonged ischemia.

PubMed Health : 59
About heart attack: A heart attack happens when the flow of oxygen-rich blood to a section of heart muscle suddenly becomes blocked and the heart can't get oxygen. If blood flow isn't restored quickly, the section of heart muscle begins to die.Heart attacks are a leading killer of both men and women in the United States. The good news is that excellent treatments are available for heart attacks. These treatments can save lives and prevent disabilities.Heart attack treatment works best when it's given right after symptoms occur. If you think you or someone else is having a heart attack (even if you're not fully sure), call 9–1–1 right away.

Wikipedia : 72 Myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow decreases or stops... more...

Description from OMIM: 608446

Related Diseases for Myocardial Infarction

Diseases in the Myocardial Infarction family:

Myocardial Infarction 2 Acute Myocardial Infarction
Posterior Myocardial Infarction

Diseases related to Myocardial Infarction via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 542)
# Related Disease Score Top Affiliating Genes
1 myocardial infarction 2 34.7 MCI2 PLAT
2 anterolateral myocardial infarction 34.5 ACE PLAT
3 atherosclerosis susceptibility 32.6 ACE OLR1 PTGIS
4 arteries, anomalies of 32.1 ACE OLR1 PLAT
5 angina pectoris 31.4 ACE PLAT
6 vascular disease 31.2 ACE OLR1 PLAT PTGIS
7 stroke, ischemic 30.9 ACE F7 PLAT PTGIS
8 cerebrovascular disease 30.8 ACE F7 PLAT
9 acute myocardial infarction 12.6
10 inferior myocardial infarction 12.4
11 posterior myocardial infarction 12.3
12 silent myocardial infarction 12.3
13 anteroseptal myocardial infarction 12.3
14 lateral myocardial infarction 12.3
15 subendocardial myocardial infarction 12.3
16 acute anterolateral myocardial infarction 12.3
17 septal myocardial infarction 12.2
18 apical myocardial infarction 12.2
19 posterolateral myocardial infarction 12.2
20 strictly posterior acute myocardial infarction 12.2
21 acute inferolateral myocardial infarction 12.2
22 posteroinferior myocardial infarction 12.2
23 inferolateral myocardial infarct 12.2
24 subendocardial infarction acute myocardial infarction 12.1
25 coronary artery disease, autosomal dominant, 1 11.8
26 coronary thrombosis 11.7
27 cardiac rupture 11.5
28 coronary heart disease 1 11.4
29 ventricular fibrillation, paroxysmal familial, 1 11.4
30 kawasaki disease 11.4
31 werner syndrome 11.2
32 acute inferoposterior infarction 11.1
33 hyperlipidemia, familial combined 11.0
34 coronary artery disease, autosomal dominant 2 11.0
35 thrombophilia due to thrombomodulin defect 11.0
36 thrombocythemia 3 11.0
37 morbid obesity and spermatogenic failure 11.0
38 chronic mountain sickness 11.0
39 hyperlipoproteinemia, type iii 11.0
40 arterial calcification of infancy 11.0
41 conn's syndrome 11.0
42 aldosterone-producing adenoma 11.0
43 hemorrhagic disease 10.8 F13A1 F7 ITGB3 PLAT
44 cardiogenic shock 10.7
45 aspirin resistance 10.7 F13A1 ITGB3
46 complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy 10.6
47 thrombosis 10.6
48 coronary artery anomaly 10.6
49 endotheliitis 10.6
50 aging 10.6

Graphical network of the top 20 diseases related to Myocardial Infarction:



Diseases related to Myocardial Infarction

Symptoms & Phenotypes for Myocardial Infarction

Clinical features from OMIM:

608446

UMLS symptoms related to Myocardial Infarction:


edema, chest pain, angina pectoris

MGI Mouse Phenotypes related to Myocardial Infarction:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.03 GUCY1A1 ITGB3 LTA MEF2A OLR1 PLAT
2 homeostasis/metabolism MP:0005376 9.97 ACE ESR1 F13A1 F7 GCLC GCLM
3 mortality/aging MP:0010768 9.73 ACE ESR1 F13A1 F7 GCLC GCLM
4 respiratory system MP:0005388 9.17 ESR1 F13A1 GUCY1A1 ITGB3 LTA MEF2A

Drugs & Therapeutics for Myocardial Infarction

PubMedHealth treatment related to Myocardial Infarction: 59

Early treatment for a heart attack can prevent or limit damage to the heart muscle. Acting fast, at the first symptoms of a heart attack, can save your life. Medical personnel can begin diagnosis and treatment even before you get to the hospital.Certain treatments usually are started right away if a heart attack is suspected, even before the diagnosis is confirmed. These include: Oxygen therapy Aspirin to thin your blood and prevent further blood clottingNitroglycerin to reduce your heart's workload and improve blood flow through the coronary arteriesTreatment for chest painOnce the diagnosis of a heart attack is confirmed or strongly suspected, doctors start treatments to try to promptly restore blood flow to the heart. The two main treatments are "clot-busting" medicines and percutaneous coronary intervention (PCI), sometimes referred to as coronary angioplasty, a procedure used to open blocked coronary arteries.

Drugs for Myocardial Infarction (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 932)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Etanercept Approved, Investigational Phase 4,Phase 1,Phase 2 185243-69-0
2
Abciximab Approved Phase 4,Phase 3,Phase 2 143653-53-6
3
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
4
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 22916-47-8 4189
5
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 46835353 6436030 5284616
6
Pravastatin Approved Phase 4,Phase 3,Phase 2 81093-37-0 54687
7
Colchicine Approved Phase 4,Phase 3,Phase 2 64-86-8 2833 6167
8
Clopidogrel Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 120202-66-6, 113665-84-2 60606
9
Ticagrelor Approved Phase 4,Phase 3,Phase 2,Phase 1 274693-27-5 9871419
10
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 55142-85-3 5472
11
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-78-2 2244
12
Bivalirudin Approved, Investigational Phase 4,Phase 3,Phase 2 128270-60-0 16129704
13
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 9005-49-6 46507594 772
14
Tenecteplase Approved Phase 4,Phase 3,Phase 2 191588-94-0
15
Tirofiban Approved Phase 4,Phase 3,Phase 2,Phase 1 144494-65-5 60947
16
Thrombin Approved, Investigational Phase 4,Phase 3,Phase 2
17
Nicorandil Approved, Investigational Phase 4,Phase 3 65141-46-0 47528
18
Eptifibatide Approved, Investigational Phase 4,Phase 3,Phase 2 188627-80-7 123610
19
Coal tar Approved Phase 4,Phase 2 8007-45-2
20
Chlorhexidine Approved, Vet_approved Phase 4 55-56-1 2713 9552079
21
Ranolazine Approved, Investigational Phase 4,Phase 3,Phase 2 95635-55-5, 142387-99-3 56959
22
Citalopram Approved Phase 4,Phase 2 59729-33-8 2771
23
Hydroxocobalamin Approved Phase 4,Phase 3,Phase 2 13422-51-0 5460373 44475014 11953898
24
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1 73590-58-6 4594
25
Pantoprazole Approved Phase 4,Phase 3 102625-70-7 4679
26
Clonidine Approved Phase 4,Phase 3,Early Phase 1 4205-90-7 2803
27
Phenprocoumon Approved, Investigational Phase 4,Phase 3 435-97-2 54680692 9908
28
Warfarin Approved Phase 4,Phase 2,Phase 3 81-81-2 54678486 6691
29
Celecoxib Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 169590-42-5 2662
30
Menthol Approved Phase 4,Phase 2,Phase 3,Early Phase 1 2216-51-5 16666
31
Cilostazol Approved, Investigational Phase 4,Phase 3 73963-72-1 2754
32
Chromium Approved Phase 4,Phase 2,Phase 3 7440-47-3 27668
33
Angiotensin II Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
34
Ramipril Approved Phase 4,Phase 3,Phase 2 87333-19-5 5362129
35
Telmisartan Approved, Investigational Phase 4,Phase 3,Phase 2 144701-48-4 65999
36
Acenocoumarol Approved, Investigational Phase 4,Phase 3 152-72-7 54676537 9052
37
Salicylic acid Approved, Investigational, Vet_approved Phase 4,Phase 3 69-72-7 338
38
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 33069-62-4 36314
39
Amiloride Approved Phase 4,Phase 3 2609-46-3, 2016-88-8 16231
40
Amlodipine Approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 88150-42-9 2162
41
Simvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 79902-63-9 54454
42
Acarbose Approved, Investigational Phase 4,Phase 3,Phase 2 56180-94-0 441184
43
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2 83-43-2 6741
44
Prednisolone Approved, Vet_approved Phase 4,Phase 2 50-24-8 5755
45
Rivaroxaban Approved Phase 4,Phase 2,Phase 3 366789-02-8
46
Ethanol Approved Phase 4,Phase 3,Early Phase 1 64-17-5 702
47
Ustekinumab Approved, Investigational Phase 4 815610-63-0
48
Desflurane Approved Phase 4 57041-67-5 42113
49
Isoflurane Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 26675-46-7 3763
50
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 2078-54-8 4943

Interventional clinical trials:

(show top 50) (show all 4414)

# Name Status NCT ID Phase Drugs
1 Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction Unknown status NCT01372930 Phase 4 Etanercept;saline
2 Sirolimus Eluting Stenting in Acute Myocardial Infarction Unknown status NCT00288210 Phase 4
3 Efficacy of Thrombosuction in Primary Percutaneous Coronary Intervention of Acute Myocardial Infarction Unknown status NCT01156662 Phase 4
4 Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study Unknown status NCT00688922 Phase 4 Pravastatin
5 Colchicine in ST-elevation Myocardial Infarction Unknown status NCT01936285 Phase 4 Colchicine 2 mg loading dose; 0.5 mg bid for 5 days;Placebo
6 Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Non-ST-elevation Myocardial Infarction Study Unknown status NCT01013038 Phase 4
7 Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial Infarction Unknown status NCT01499407 Phase 4 Abciximab
8 Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function Unknown status NCT02123004 Phase 4 Ticagrelor;Clopidogrel
9 Comparison of Primary PCI vs. Post-thrombolysis PCI as Reperfusion Strategies in STEMI Unknown status NCT02268669 Phase 4
10 Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI Unknown status NCT00229515 Phase 4
11 Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction Unknown status NCT00976092 Phase 4 Prasugrel;Bivalirudin;Clopidogrel;Heparin
12 Microvascular Reperfusion Utilizing Sonothrombolysis in Acute Myocardial Infarction (MRUSMI TRIAL) Unknown status NCT02170103 Phase 4 Microbubbles
13 Anti-Restenosis After AMI by Erythropoietin Unknown status NCT00423020 Phase 4 Erythropoietin
14 Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction. Unknown status NCT01080638 Phase 4 glycoprotein IIb/IIIa inhibitor (abciximab)
15 Effects of Intensive Statin Treatment on Left Ventricular Function Unknown status NCT01936103 Phase 4 standard group;intensive group
16 Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction Unknown status NCT02435797 Phase 4 Nicorandil;normal saline
17 IRIS : Use of Implantable Defibrillator in High-Risk Patients Early After Acute Myocardial Infarction Unknown status NCT00157768 Phase 4
18 Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty Unknown status NCT02592694 Phase 4 cocktail
19 Thrombus Aspiration in Patients With STEMI Unknown status NCT02606435 Phase 4
20 Optimizing Infarct Size by Transforming Emergent Stenting Into an Elective Procedure Study Unknown status NCT01462188 Phase 4
21 A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction Unknown status NCT01942070 Phase 4
22 Effect of Conditioning on Myocardial Damage in STEMI Unknown status NCT02158468 Phase 4
23 Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI Unknown status NCT01781715 Phase 4
24 Comparison of Biolimus A9 and Everolimus Drug-Eluting Stents in Patients With ST Segment Elevation Myocardial Infarction Unknown status NCT00888758 Phase 4
25 Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI Unknown status NCT01158846 Phase 4 prasugrel/bivalirudin;clopidogrel/abciximab
26 Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes Unknown status NCT02126202 Phase 4
27 Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin Unknown status NCT00370045 Phase 4 Bivalirudin with and without eptifibatide
28 Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome Unknown status NCT01372839 Phase 4 Atorvastatin;Statin
29 MGuard Stent in ST-elevation Myocardial Infarction Unknown status NCT01124942 Phase 4
30 Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention Unknown status NCT01968577 Phase 4 Rosuvastatin
31 Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI Unknown status NCT02233790 Phase 4 Ticagrelor;Clopidogrel
32 A Trial to Evaluate Efficacy of Heart-protecting Musk Pill Unknown status NCT01897805 Phase 4 Heart-protecting Musk Pill;Placebo
33 Local Thrombolytics Before Thrombectomy in STEMI Unknown status NCT01568931 Phase 4 Urokinase;Saline
34 Thrombus Aspiration for OcLuded Coronary Artery Enhanced With Distal Injection Of Abciximab Unknown status NCT01383785 Phase 4
35 N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure Unknown status NCT00692718 Phase 4 Epadel, Eicosapentaenoic acid
36 the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery. Unknown status NCT02158559 Phase 4 Danhong Injection;Normal Saline
37 Polish-Italian-Hungarian RAndomized ThrombEctomy Trial Unknown status NCT00377650 Phase 4
38 Dissecting the Role of Distal Embolization of Athero-thrombotic Material in Primary PCI: the ThrombOticBurden and mIcrovAscularobStruction (TOBIAS) Study. Unknown status NCT01914055 Phase 4
39 A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions Unknown status NCT00825773 Phase 4
40 Treating Acute MI Patients With Aggrastat on Their Way to Hospital Unknown status NCT00300833 Phase 4 Tirofiban
41 Ranolazine Loading to Prevent PCI-induced Myocardial Injury Unknown status NCT01491061 Phase 4 Ranolazine;Placebo
42 Post-MI PET Scan Imaging of Inflammation Unknown status NCT02281305 Phase 4 Colchicine
43 Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis Unknown status NCT02048085 Phase 4 Ticagrelor;Clopidogrel
44 DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome Unknown status NCT00140257 Phase 4 Escitalopram
45 HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study) Unknown status NCT00106886 Phase 4 Folic acid, vitamin B6 and B12 or placebo
46 Zotarolimus and Everolimus-Eluting Stents ProsPectively Compared in Real World Unknown status NCT00768846 Phase 4
47 Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome Unknown status NCT02446730 Phase 4 Prasugel;Clopidogrel
48 Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor . Unknown status NCT02032303 Phase 4 Ticagrelor loading;Prasugrel loading
49 Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN) Unknown status NCT01735227 Phase 4 omeprazole;Pantoprazole
50 Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing Unknown status NCT00698607 Phase 4 6-month clopidogrel therapy;12-month clopidogrel therapy

Search NIH Clinical Center for Myocardial Infarction

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Myocardial Infarction cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Myocardial Infarction:
ADRCs, adipose-derived regenerative cells for cardiovascular disease
AMI MultiStem
AMR-001, bone marrow-derived CD34+ cells for myocardial infarction
Autologous bone marrow-derived mononuclear cells for myocardial infarction
Bone marrow or peripheral blood-derived stem cells for treatment of myocardial ischemia
Bone marrow-derived adult mononuclear cells for heart diseases
Bone marrow-derived CD133+ vs. mononuclear cells for treatment of myocardial infarction
Bone marrow-derived mesenchymal stem cells for treatment of myocardial ischemia
Bone marrow-derived mononuclear cells for acute myocardial infarction
Bone marrow-derived mononuclear cells for chronic myocardial infarction
Bone marrow-derived mononuclear cells for myocardial infarction
Bone marrow-derived mononuclear cells for myocardial infarction
Bone marrow-derived mononuclear cells for myocardial infarction
Bone marrow-derived mononuclear cells for treatment of myocardial infarction
Bone marrow-derived progenitor cells for myocardial infarction
Bone marrow-derived stem cells for treatment of ischemic cardiomyopathy
Cardiosphere-derived autologous stem cells for reverse ventricular dysfunction
Cardiosphere-derived cells for the treatment of myocardial infarction
CD133+ bone marrow-derived stem cells in conjuction with coronary artery bypass grafting
Combination therapy of mononuclear cells with laser for coronary disease
Early endothelial progenitor cells for acute myocardial infarction
Embryonic stem cell-derived cardiomyocyte transplantation for myocardial infarction
Embryonic stem cell-derived cardiomyocytes for treatment of myocardial infarction
Enriched bone marrow-derived progenitor cells for heart diseases
Hearticellgram
Hydrogels with cardiomyocytes for myocardial repair
Induced pluripotent stem cells for treatment of myocardial infarction
itMSC, bone marrow-derived mesenchymal stem cells for cardiovascular diseases
Mesenchymal precursor cells for cardiovascular diseases
Mesendo, stem cell combination for treatment of cardiovascular diseases
MyoCell
Prochymal
Sca-1-positive cardiac progenitor cells for treatment of myocardial infarction
Stem cell therapy for treatment of acute myocardial infarction
StempeucelAMI
Umbilical cord blood-derived CD133 positive cells for treatment of myocardial infarction
Embryonic/Adult Cultured Cells Related to Myocardial Infarction:
Adipose-derived stem and regenerative cells PMIDs: 21082397 22281257
Bone marrow-derived adherent progenitor cells (MultiStem) PMIDs: 23111647 22004910 22052917 21175285
Bone marrow-derived autologous CD34+cells (AMR-001) PMIDs: 21167340
Bone marrow-derived mononuclear cells PMIDs: 19002124
Bone marrow-derived mononuclear cells
Peripheral blood-derived hematopoietic stem cells (family)
Bone marrow-derived mononuclear cells PMIDs: 22137069 19699857 20445812 20524773
Bone marrow-derived CD133+ hematopoietic stem cells
Bone marrow-derived mononuclear cells (family) PMIDs: 16889856 16382259 22192151 21414223 21392602 22940024
Bone marrow-derived mesenchymal stem cells (family)
Bone marrow-derived mononuclear cells
Bone marrow-derived mesenchymal stem cells PMIDs: 16889856 16382259
Bone marrow-derived mononuclear cells PMIDs: 22834565
Bone marrow-derived mononuclear cells PMIDs: 22834565
Bone marrow-derived mononuclear cells
Bone marrow-derived progenitor cells PMIDs: 20448133 16159812 18293890
Porcine bone marrow-derived mesenchymal stem cells PMIDs: 21392602 22940024 19958962
Bone marrow-derived mesenchymal stem cells PMIDs: 21392602 22940024
Cardiosphere-derived cells PMIDs: 22336189 17283259
Bone marrow-derived CD133+ cells PMIDs: 17320570
Peripheral blood-derived endothelial progenitor cells PMIDs: 21362705 22239631
eNOS-transfected endothelial progenitor cells PMIDs: 21362705 22239631
Cardiomyocyte-like cells PMIDs: 17980256 21783246
Cardiomyocyte-like cells PMIDs: 22040108
Bone marrow-derived progenitor cells PMIDs: 23362308 22936827 18794392 16990384 16990385 22651868
Neonatal rat ventricular cardiomyocytes PMIDs: 21783246
DR4 induced pluripotent stem cells PMIDs: 23568891
Mesenchymal Precursor Cells (STRO-3 selected) PMIDs: 20850099 21155976
Bone marrow-derived mesenchymal stem cells PMIDs: 21323410 20631864
Bone marrow-derived mononuclear cells PMIDs: 21323410 20631864
Skeletal myoblasts (MyoCell PMIDs: 19051139 15615560 16446778
Bone marrow-derived mesenchymal stem cells PMIDs: 19958962
Cardiac progenitor cells (Sca1+) PMIDs: 21980409
Bone marrow-derived CD34+/CXCR4+ cells
Bone marrow-derived mesenchymal stem cells (Stempeucel PMIDs: 18720444
Umbilical cord blood-derived CD133+ cells PMIDs: 16195418

Cochrane evidence based reviews: myocardial infarction

Genetic Tests for Myocardial Infarction

Genetic tests related to Myocardial Infarction:

# Genetic test Affiliating Genes
1 Myocardial Infarction 1 28 ESR1 F13A1 F7 GCLC GCLM ITGB3 LGALS2 LRP8 LTA MIAT OLR1 PSMA6 TNFSF4
2 Myocardial Infarction 28

Anatomical Context for Myocardial Infarction

MalaCards organs/tissues related to Myocardial Infarction:

38
Heart, Bone, Endothelial, Testes, Kidney, Bone Marrow, Brain
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Myocardial Infarction:
# Tissue Anatomical CompartmentCell Relevance
1 Bone Bone Marrow Bone Marrow Stromal Cells Potential therapeutic candidate
2 Limb Pelvic Girdle Bone Marrow Stromal Cells Potential therapeutic candidate
3 Heart Myocardium Cardiomyocytes Affected by disease

Publications for Myocardial Infarction

Articles related to Myocardial Infarction:

(show top 50) (show all 7275)
# Title Authors Year
1
Effect of a Quality Improvement Intervention on Clinical Outcomes in Patients in India With Acute Myocardial Infarction: The ACS QUIK Randomized Clinical Trial. ( 29450524 )
2018
2
Gambogic acid exerts cardioprotective effects in a rat model of acute myocardial infarction through inhibition of inflammation, iNOS and NF-I_B/p38 pathway. ( 29434760 )
2018
3
rLj-RGD3, a novel recombinant toxin protein from Lampetra japonica, prevents coronary thrombosis-induced acute myocardial infarction by inhibiting platelet functions in rats. ( 29407168 )
2018
4
Reperfusion delay in patients with high-risk ST-segment elevation myocardial infarction: every minute counts, much more than suspected. ( 29452358 )
2018
5
Doppler Versus Thermodilution-Derived Coronary Microvascular Resistance to Predict Coronary Microvascular Dysfunction in Patients With Acute Myocardial Infarction or Stable Angina Pectoris. ( 29132649 )
2018
6
Ghrelin prevents cardiac cell apoptosis during cardiac remodelling post experimentally induced myocardial infarction in rats via activation of Raf-MEK1/2-ERK1/2 signalling. ( 29447000 )
2018
7
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Disease. ( 29449325 )
2018
8
Managing in-hospital quality improvement: An importance-performance analysis to set priorities for ST-elevation myocardial infarction care. ( 29448818 )
2018
9
Buckberg's blood cardioplegia for protection of adult and senile myocardium in a rat in vitro model of acute myocardial infarction. ( 29432894 )
2018
10
Accelerated idioventricular rhythm degenerating into bidirectional ventricular tachycardia following acute myocardial infarction. ( 29429799 )
2018
11
Rapid increases in nitrogen oxides are associated with acute myocardial infarction: A case-crossover study. ( 29446990 )
2018
12
Revision: prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock-a substudy of the IABP-SHOCK II-trial. ( 29423774 )
2018
13
Effects of smoke-free air law on acute myocardial infarction hospitalization in Indianapolis and Marion County, Indiana. ( 29426315 )
2018
14
Circulating miR-379 as a potential novel biomarker for diagnosis of acute myocardial infarction. ( 29424915 )
2018
15
Is index procedure complete revascularization really essential for ST-elevation myocardial infarction with cardiogenic shock? ( 29430782 )
2018
16
Correction to: Air quality and acute myocardial infarction in adults during the 2016 Hangzhou G20 summit. ( 29450769 )
2018
17
Primary percutaneous coronary intervention during ST elevation myocardial infarction in prosthetic valve endocarditis: a case report. ( 29426281 )
2018
18
Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. ( 29452351 )
2018
19
Optimal course of treatment in acute cardiogenic shock complicating myocardial infarction. ( 29310471 )
2018
20
Aspirin Withdrawal in Patients Treated with Ticagrelor Presenting with Non-ST Elevation Myocardial Infarction. ( 29443445 )
2018
21
TG haplotype in the LRP8 is associated with myocardial infarction in south Indian population. ( 29032149 )
2018
22
Persistent Inflammation, Stem Cell-Induced Systemic Anti-Inflammatory Effects, and Need for Repeated Stem Cell Injections: Critical Concepts Influencing Optimal Stem Cell Strategies for Treating Acute Myocardial Infarction and Heart Failure. ( 29440037 )
2018
23
Fried food intake and risk of nonfatal acute myocardial infarction in the Costa Rica Heart Study. ( 29447246 )
2018
24
Acute myocardial infarction in a 25-year-old woman with sitosterolemia. ( 29174072 )
2018
25
Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock. ( 29347907 )
2018
26
Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock. ( 29424484 )
2018
27
Long-term Prognosis and Clinical Characteristics of Patients with Newly Diagnosed Diabetes Mellitus Detected after First Acute Myocardial Infarction: from KAMIR-NIH Registry. ( 29441746 )
2018
28
Clinical Significance of Newly Diagnosed Diabetes Mellitus in the Era of DES for Acute Myocardial Infarction. ( 29441749 )
2018
29
Effects of cardiac resynchronization therapy after inferior myocardial infarction on secondary mitral regurgitation and mitral valve geometry. ( 29222864 )
2018
30
A foreign older diabetic woman with an acute myocardial infarction: when cognitive biases in clinical decision-making become especially important. ( 29437739 )
2018
31
Two-hour post-challenge glucose is a better predictor of adverse outcome after myocardial infarction than fasting or admission glucose in patients without diabetes. ( 29450734 )
2018
32
Comprehensive electrocardiogram-to-device time for primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A report from the American Heart Association mission: Lifeline program. ( 29447789 )
2018
33
Acute Myocardial Infarction in a Patient with Isolated Dextrocardia. ( 29431312 )
2018
34
Impact of generalized anxiety disorder (GAD) on prehospital delay of acute myocardial infarction patients. Findings from the multicenter MEDEA study. ( 29383439 )
2018
35
Shift work, parental cardiovascular disease and myocardial infarction in males. ( 29444274 )
2018
36
Ac-SDKP decreases mortality and cardiac rupture after acute myocardial infarction. ( 29364896 )
2018
37
Impact of metabolic syndrome on clinical severity and long term prognosis in patients with myocardial infarction with ST segment elevation. ( 29452307 )
2018
38
MicroRNAs in acute myocardial infarction: Evident value as novel biomarkers? ( 29424735 )
2018
39
Blood cardioplegia for cardiac surgery in acute myocardial infarction: rat experiments with two widely used solutions. ( 29452370 )
2018
40
Acute stress disorder and C-reactive protein in patients with acute myocardial infarction. ( 29243511 )
2018
41
Myocardial infarction and thrombophilia: Do not miss the right diagnosis! ( 29254740 )
2018
42
A New Secretory Peptide of Natriuretic Peptide Family, Osteocrin, Suppresses the Progression of Congestive Heart Failure After Myocardial Infarction. ( 29326144 )
2018
43
Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation. ( 29447733 )
2018
44
Silent Myocardial Infarction: Listen to the Evidence. ( 29301632 )
2018
45
Brain Natriuretic Peptide Levels in Acute Inferior Myocardial Infarction. ( 29416586 )
2018
46
Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support. ( 29400656 )
2018
47
An inferior myocardial infarction with conduction abnormalities. ( 29304949 )
2018
48
Adiponectin gene variants and decreased adiponectin plasma levels are associated with the risk of myocardial infarction in young age. ( 29196254 )
2018
49
Chart validation of inpatient ICD-9-CM administrative diagnosis codes for acute myocardial infarction (AMI) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database. ( 29446185 )
2018
50
Delayed Cardiac Rupture Induced by Traumatic Myocardial Infarction: Consequence of a 45-Magnum Blast Injury; A Comprehensive Case Review. ( 29379803 )
2018